Calcium channel blocker therapy in black hypertensive patients

Comment

Lizzy M Brewster et al. Am J Hypertens. 2010 Mar.

. 2010 Mar;23(3):218; author reply 219.

doi: 10.1038/ajh.2009.268.

No abstract available

Comment on

Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis.
Nguyen TT, Kaufman JS, Whitsel EA, Cooper RS. Nguyen TT, et al. Am J Hypertens. 2009 Aug;22(8):911-7. doi: 10.1038/ajh.2009.100. Epub 2009 Jun 4. Am J Hypertens. 2009. PMID: 19498341 Free PMC article.

Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence.
Bloch MJ, Basile JN. Bloch MJ, et al. J Clin Hypertens (Greenwich). 2011 Jan;13(1):1-4. doi: 10.1111/j.1751-7176.2010.00411.x. Epub 2010 Dec 13. J Clin Hypertens (Greenwich). 2011. PMID: 21214713 Free PMC article. No abstract available.
Pharmacologic therapy of hypertension in blacks.
Hall WD. Hall WD. J Clin Hypertens. 1987 Sep;3(3 Suppl):108S-113S. J Clin Hypertens. 1987. PMID: 3312505 Review.
Diuretics are color blind.
Neaton JD, Kuller LH. Neaton JD, et al. JAMA. 2005 Apr 6;293(13):1663-6. doi: 10.1001/jama.293.13.1663. JAMA. 2005. PMID: 15811986 No abstract available.
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M, Tocci G. Volpe M, et al. Vasc Health Risk Manag. 2012;8:371-80. doi: 10.2147/VHRM.S28359. Epub 2012 Jun 11. Vasc Health Risk Manag. 2012. PMID: 22745561 Free PMC article. Review.
Calcium channel blocker.
Li CJ, Shi ZD. Li CJ, et al. Clin Ther. 2010 Feb;32(2):396; author reply 397. doi: 10.1016/j.clinthera.2010.02.007. Clin Ther. 2010. PMID: 20206797 No abstract available.